Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma
ObjectiveThis study investigates the effects of Paromomycin on SUMOylation-related pathways in glioblastoma (GBM), specifically targeting HDAC1 inhibition.MethodsUsing TCGA and GTEx datasets, we identified SUMOylation-related genes associated with GBM prognosis. Molecular docking analysis suggested...
Saved in:
| Main Authors: | Zhong Min, Yuejie Guo, Luo Ning |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1490878/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coordinated regulation of IGF1R by HIF1α and HIF2α enhances chemoresistance in glioblastoma
by: Bin Liao, et al.
Published: (2025-04-01) -
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
by: Francesco Spallotta, et al.
Published: (2024-11-01) -
Investigating Serum and Placental Levels of IGF-1 and IGF-1R in Preeclampsia Patients and Their Clinical Implications
by: Su J, et al.
Published: (2025-03-01) -
IGF1/IGF1R signaling promotes the expansion of liver CSCs and serves as a potential therapeutic target in HCC
by: Qiuju Tian, et al.
Published: (2025-06-01) -
Identification of functional rare coding variants in IGF-1 gene in humans with exceptional longevity
by: Amanat Ali, et al.
Published: (2025-03-01)